MTEX
Mannatech, Incorporated8.33
+0.01+0.12%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
15.83MP/E (TTM)
-Basic EPS (TTM)
-0.86Dividend Yield
0%Recent Filings
10-Q
Q3 FY2025 results
Mannatech posted Q3 net sales of $29.2M, down 8.1% y/y yet up sharply q/q from softer H1, with gross margin expanding to 76.4% from 74.5% on higher prices and lower inventory reserves. Operating income hit $2.0M, up 126% y/y, driving $1.9M net income ($1.01 diluted EPS on 1.9M shares); YTD sales fell 8.4% to $81.4M with $3.9M net loss, tied to $2.6M foreign exchange losses. Asia/Pacific drove 64% of sales, steady despite Americas drop. Cash sits at $7.1M, long-term debt steady at $2.9M (16% notes due Mar 2027). Debt matures in 2027. Tariffs risk supply chain costs.
8-K
Q3 sales dip, profit surge
Mannatech reported Q3 net sales of $29.2M, down 8.1% from $31.7M last year amid slowing regional demand, yet swung to $1.9M net income from a $0.3M loss. Gross margins climbed to 76.4% on higher prices and fewer inventory reserves; operating income doubled to $2.0M. Cash fell to $7.1M. Tariffs threaten costs.
8-K
Mannatech extends board loans
Mannatech extended three unsecured loans totaling $3.6 million from board members J. Stanley Fredrick, Tyler Rameson via Jade Capital, and Kevin Robbins, with $2.9 million now outstanding after a $0.7 million prepayment. The notes, originally due earlier, now mature on March 31, 2027, supporting ongoing working capital needs without altering other terms. Prepayment remains penalty-free. This insider extension buys time amid liquidity pressures.
10-Q
Q2 FY2025 results
Mannatech's Q2 net sales dipped 7.4% year-over-year to $25.7 million, with Asia/Pacific holding steady at 59.5% of the mix despite a 3.8% drop, while Americas fell 12.6% on fewer active associates. Gross margin slipped to 73.6% from 77.1%, squeezed by higher product costs and freight, yet operating loss widened modestly to $1.4 million as commissions eased 18%. A $2.7 million foreign exchange hit turned a slim prior-year loss into a $4.3 million net shortfall, or $2.27 per diluted share—anti-dilutive options excluded. Cash drained to $5.5 million amid $5.1 million operating outflows, but $2.9 million in unsecured notes at 16% due 2026 bolsters liquidity. Tariffs loom as a supply chain wildcard.
8-K
Q2 sales drop 7.4%
Mannatech reported Q2 2025 net sales of $25.7 million, down 7.4% from $27.7 million in Q2 2024, driven by weakened economic conditions curbing demand in key regions. Gross margin slipped to 73.6% amid higher freight and promotion costs, while commissions fell 14.4% to $9.5 million, yet operating loss widened to $1.4 million. Cash dwindled 51.5% to $5.5 million; recruiting plunged 22.7%. Tariffs threaten further cost pressures.
IPO
Website
Employees
Sector
Industry
AIXN
AIXIN LIFE INTERNATIONAL INC
0.48+0.32
CYAN
Cyanotech Corp.
0.40+0.01
FTLF
FitLife Brands, Inc.
18.10-0.28
HLF
Herbalife Ltd.
14.45-0.45
HYEX
HEALTHY EXTRACTS INC.
1.99-0.22
MCLE
MEDICALE CORP.
0.12+0.00
NATR
Nature's Sunshine Products, Inc
22.38-0.85
PSYCF
Psyched Wellness Ltd.
0.01-0.00
SNYR
Synergy CHC Corp.
1.85-0.11
STEK
Stemtech Corp.
0.00-0.00